FORTIS - IntraDay Trade Analysis with Live Signals
← Back to ListKey Parameters
⭐ IntraDay Trade Rating: 3.2
✅ Positive
The stock is experiencing a significant quarterly profit increase (382%) and has shown positive DII holdings (0.88%). Furthermore, the recent IPO of Manipal Health at a premium indicates strong investor sentiment within the healthcare sector.
⚠️ Limitation
Despite the positive momentum, the high P/E ratio (362) suggests overvaluation, and the MACD is negative indicating downward pressure. The PEG ratio of 6.81 also points to potential overvaluation given expected growth rates.
📉 Company Negative News
None found
📈 Company Positive News
None found
🏭 Industry
Fortis Healthcare operates within the healthcare sector, which currently benefits from increasing private healthcare spending and a growing aging population in India. Recent IPO success for Manipal Health signals investor confidence in this area.
🧾 Conclusion
A potential entry point could be at 930 ₹ with an initial stop-loss set at 915 ₹, targeting profit taking around 945 ₹. Given the momentum and increased volume, a cautious approach is recommended, monitoring for further upward movement before committing to larger positions. Overall, it’s a moderately attractive intraday trading candidate due to recent positive developments but carries valuation risks.